Anti-tumor necrosis factor alpha treatment with adalimumab improves significantly endothelial function and decreases inflammatory process in patients with chronic psoriasis

被引:48
作者
Avgerinou, Georgia [2 ]
Tousoulis, Dimitris [1 ]
Siasos, Gerasimos [1 ]
Oikonomou, Evaggelos [1 ]
Maniatis, Konstantinos [1 ]
Papageorgiou, Nikolaos [1 ]
Paraskevopoulos, Theodoros [1 ]
Miliou, Antigoni [1 ]
Koumaki, Dimitra [2 ]
Latsios, George [1 ]
Therianiou, Anastasia [1 ,2 ]
Trikas, Athanasios [1 ]
Kampoli, Anna Maria [1 ]
Stefanadis, Christodoulos [1 ]
机构
[1] Univ Athens, Sch Med, Hippokrat Hosp, Cardiol Unit 1, Athens 11528, Greece
[2] Univ Athens, Dept Dermatol 1, A Sygros Hosp, Athens 11528, Greece
关键词
Inflammation; Adalimumab; Psoriasis; Endothelium; REPORTED OUTCOMES; TRIAL; RISK;
D O I
10.1016/j.ijcard.2011.06.112
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:382 / 383
页数:2
相关论文
共 50 条
[31]   Impact of anti-tumor necrosis factor treatment on lipid profiles in Korean patients with ankylosing spondylitis [J].
Kwon, Inbeom ;
Choi, Nayeon ;
Shin, Ji Hui ;
Lee, Seunghun ;
Nam, Bora ;
Kim, Tae-Hwan .
JOURNAL OF RHEUMATIC DISEASES, 2024, 31 (01) :41-48
[32]   Dramatic Response to Ustekinumab Treatment in a Patient with Ankylosing Spondylitis and Crohn's Disease and Anti-tumor Necrosis Factor-alpha Drug Induced Psoriasis [J].
Kilic, Sevilay ;
Resorlu, Hatice ;
Ekinci, Alper ;
Keskin, Ayse Selcen Bulut .
TURK OSTEOPOROZ DERGISI-TURKISH JOURNAL OF OSTEOPOROSIS, 2020, 26 (03) :197-200
[33]   Tumor necrosis factor-α inhibition improves endothelial function and decreases arterial stiffness in estrogen-deficient postmenopausal women [J].
Moreau, Kerrie L. ;
Deane, Kevin D. ;
Meditz, Amie L. ;
Kohrt, Wendy M. .
ATHEROSCLEROSIS, 2013, 230 (02) :390-396
[34]   Multiple sclerosis following anti-tumor necrosis factor-alpha therapy for psoriasis: first case in Italy? [J].
Napolitano, Maddalena ;
Balato, Nicola ;
Ayala, Fabio ;
Cirillo, Teresa ;
Balato, Anna .
GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2018, 153 (04) :567-572
[35]   Eosinophilia - A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis [J].
Chiriac, Anca ;
Brzezinski, Piotr ;
Stolnicu, Simona ;
Podoleanu, Cristian ;
Moldovan, Cosmin ;
Molnar, Calin ;
Taranu, Tatiana .
JOURNAL OF DERMATOLOGICAL TREATMENT, 2016, 27 (02) :110-113
[36]   Strategies for Treatment With Anti-Tumor Necrosis Factor Agents in Psoriasis Maintaining Efficacy and Safety for the Long Haul [J].
Gordon, Kenneth B. ;
Gandhi, Mona .
ARCHIVES OF DERMATOLOGY, 2010, 146 (02) :186-188
[37]   Anti-tumor necrosis factor-α blockade improves insulin resistance in patients with rheumatoid arthritis [J].
Gonzalez-Gay, MA ;
De Matias, JM ;
Gonzalez-Juanatey, C ;
Garcia-Porrua, C ;
Sanchez-Andrade, A ;
Martin, J ;
Llorca, J .
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2006, 24 (01) :83-86
[38]   Efficacy and Safety of Anti-Tumor Necrosis Factor Alpha in Very Early Onset Inflammatory Bowel Disease [J].
Collen, Lauren, V ;
Mitsialis, Vanessa ;
Kim, David Y. ;
Bresnahan, Mairead ;
Yang, Jessica ;
Tuthill, Margaret ;
Combs, Abigail ;
Barends, Jared ;
Field, Michael ;
Liu, Enju ;
Bearup, Richelle ;
Okoroafor, Ibeawuchi ;
Klein, Christoph ;
Muise, Aleixo M. ;
Bousvaros, Athos ;
Ouahed, Jodie ;
Snapper, Scott B. .
INFLAMMATORY BOWEL DISEASES, 2023, 30 (09) :1443-1453
[39]   A safety assessment of anti-tumor necrosis factor alpha therapy for treatment of Crohn's disease [J].
Papamichael, Konstantinos ;
Mantzaris, Gerassimos J. ;
Peyrin-Biroulet, Laurent .
EXPERT OPINION ON DRUG SAFETY, 2016, 15 (04) :493-501
[40]   Stricturing and Fistulizing Crohn’s Disease Is Associated with Anti-tumor Necrosis Factor-Induced Psoriasis in Patients with Inflammatory Bowel Disease [J].
Adam V. Weizman ;
Robyn Sharma ;
N. M. Afzal ;
Wei Xu ;
Scott Walsh ;
Joanne M. Stempak ;
Geoffrey C. Nguyen ;
Ken Croitoru ;
A. Hillary Steinhart ;
Mark S. Silverberg .
Digestive Diseases and Sciences, 2018, 63 :2430-2438